nomifensine has been researched along with Dyskinesia, Drug-Induced in 8 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with nomifensine alone (3 mg/kg) also induced dyskinesias." | 1.33 | Dyskinesias in normal squirrel monkeys induced by nomifensine and levodopa. ( Di Monte, DA; Langston, JW; Protell, P; Quik, M; Tan, LC; Togasaki, DM, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sahin, G | 1 |
| Thompson, LH | 1 |
| Lavisse, S | 1 |
| Ozgur, M | 1 |
| Rbah-Vidal, L | 1 |
| Dollé, F | 1 |
| Hantraye, P | 1 |
| Kirik, D | 1 |
| Togasaki, DM | 1 |
| Protell, P | 1 |
| Tan, LC | 1 |
| Langston, JW | 1 |
| Di Monte, DA | 1 |
| Quik, M | 1 |
| Broekkamp, CL | 1 |
| Gibson, AC | 1 |
| Sandyk, R | 2 |
| Gillman, MA | 1 |
| Koritar, E | 1 |
| Rapp, MS | 1 |
8 other studies available for nomifensine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Differential dopamine receptor occupancy underlies L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Topics: Animals; Benzamides; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Extracellular Space | 2014 |
Dyskinesias in normal squirrel monkeys induced by nomifensine and levodopa.
Topics: Animals; Drug Combinations; Drug Synergism; Dyskinesia, Drug-Induced; Female; Levodopa; Nomifensine; | 2005 |
Stereotypy and dyskinesias provoked in cats differentiate directly and indirectly-acting psychomotor stimulants.
Topics: Animals; Apomorphine; Cats; Dextroamphetamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Nom | 1982 |
Nomifensine and dyskinesia.
Topics: Aged; Dyskinesia, Drug-Induced; Humans; Isoquinolines; Male; Nomifensine; Tongue Diseases | 1981 |
Nomifensine-induced orofacial dyskinesia and Sydenham's chorea.
Topics: Chorea; Dyskinesia, Drug-Induced; Facial Muscles; Female; Humans; Middle Aged; Mouth; Nomifensine; S | 1987 |
Nomifensine exacerbates orofacial dyskinesia in hypothyroidism.
Topics: Aged; Dyskinesia, Drug-Induced; Facial Muscles; Female; Humans; Hypothyroidism; Isoquinolines; Nomif | 1985 |
Nomifensine-induced dyskinesia.
Topics: Aged; Bipolar Disorder; Dyskinesia, Drug-Induced; Humans; Isoquinolines; Male; Nomifensine | 1985 |
Nomifensine-induced dyskinesia.
Topics: Aged; Dyskinesia, Drug-Induced; Humans; Nomifensine | 1985 |